Skip to main content
PMC home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 2003 Dec;111(16):1933–1938. doi: 10.1289/ehp.6400

Silica exposure and systemic vasculitis.

Karen B Mulloy 1
PMCID: PMC1241769  PMID: 14644669

Abstract

Work in Department of Energy (DOE) facilities has exposed workers to multiple toxic agents leading to acute and chronic diseases. Many exposures were common to numerous work sites. Exposure to crystalline silica was primarily restricted to a few facilities. I present the case of a 63-year-old male who worked in DOE facilities for 30 years as a weapons testing technician. In addition to silica, other workplace exposures included beryllium, various solvents and heavy metals, depleted uranium, and ionizing radiation. In 1989 a painful macular skin lesion was biopsied and diagnosed as leukocytoclastic vasculitis. By 1992 he developed gross hematuria and dyspnea. Blood laboratory results revealed a serum creatinine concentration of 2.1 mg/dL, ethrythrocyte sedimentation rate of 61 mm/hr, negative cANCA (antineutrophil cytoplasmic antibody cytoplasmic pattern), positive pANCA (ANCA perinuclear pattern), and antiglomerular basement membrane negative. Renal biopsy showed proliferative (crescentric) and necrotizing glomerulonephritis. The patient's diagnoses included microscopic polyangiitis, systemic necrotizing vasculitis, leukocytoclastic vasculitis, and glomerulonephritis. Environmental triggers are thought to play a role in the development of an idiopathic expression of systemic autoimmune disease. Crystalline silica exposure has been linked to rheumatoid arthritis, scleroderma, systemic lupus erythematosus, rapidly progressive glomerulonephritis and some of the small vessel vasculitides. DOE workers are currently able to apply for compensation under the federal Energy Employees Occupational Illness Compensation Program (EEOICP). However, the only diseases covered by EEOICP are cancers related to radiation exposure, chronic beryllium disease, and chronic silicosis.

Full Text

The Full Text of this article is available as a PDF (668.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Booth Anthony D., Almond Mike K., Burns Aine, Ellis Peter, Gaskin Gill, Neild Guy H., Plaisance Martin, Pusey Charles D., Jayne David R. W., Pan-Thames Renal Research Group Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study. Am J Kidney Dis. 2003 Apr;41(4):776–784. doi: 10.1016/s0272-6386(03)00025-8. [DOI] [PubMed] [Google Scholar]
  2. CAPLAN A. Certain unusual radiological appearances in the chest of coal-miners suffering from rheumatoid arthritis. Thorax. 1953 Mar;8(1):29–37. doi: 10.1136/thx.8.1.29. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Calvert G. M., Steenland K., Palu S. End-stage renal disease among silica-exposed gold miners. A new method for assessing incidence among epidemiologic cohorts. JAMA. 1997 Apr 16;277(15):1219–1223. [PubMed] [Google Scholar]
  4. D'Cruz D. Autoimmune diseases associated with drugs, chemicals and environmental factors. Toxicol Lett. 2000 Mar 15;112-113:421–432. doi: 10.1016/s0378-4274(99)00220-9. [DOI] [PubMed] [Google Scholar]
  5. Danning C. L., Illei G. G., Boumpas D. T. Vasculitis associated with primary rheumatologic diseases. Curr Opin Rheumatol. 1998 Jan;10(1):58–65. doi: 10.1097/00002281-199801000-00009. [DOI] [PubMed] [Google Scholar]
  6. Dick J. A., Morgan W. K., Muir D. F., Reger R. B., Sargent N. The significance of irregular opacities on the chest roentgenogram. Chest. 1992 Jul;102(1):251–260. doi: 10.1378/chest.102.1.251. [DOI] [PubMed] [Google Scholar]
  7. González-Gay M. A., García-Porrúa C. Epidemiology of the vasculitides. Rheum Dis Clin North Am. 2001 Nov;27(4):729–749. doi: 10.1016/s0889-857x(05)70232-5. [DOI] [PubMed] [Google Scholar]
  8. Gregorini G., Ferioli A., Donato F., Tira P., Morassi L., Tardanico R., Lancini L., Maiorca R. Association between silica exposure and necrotizing crescentic glomerulonephritis with p-ANCA and anti-MPO antibodies: a hospital-based case-control study. Adv Exp Med Biol. 1993;336:435–440. doi: 10.1007/978-1-4757-9182-2_77. [DOI] [PubMed] [Google Scholar]
  9. Gregorini G., Tira P., Frizza J., D'Haese P. C., Elseviers M. M., Nuyts G., Maiorca R., De Broe M. E. ANCA-associated diseases and silica exposure. Clin Rev Allergy Immunol. 1997 Spring;15(1):21–40. doi: 10.1007/BF02828275. [DOI] [PubMed] [Google Scholar]
  10. Honma K., Chiyotani K. Diffuse interstitial fibrosis in nonasbestos pneumoconiosis--a pathological study. Respiration. 1993;60(2):120–126. doi: 10.1159/000196185. [DOI] [PubMed] [Google Scholar]
  11. Jones R. N., Turner-Warwick M., Ziskind M., Weill H. High prevalence of antinuclear antibodies in sandblasters' silicosis. Am Rev Respir Dis. 1976 Mar;113(3):393–395. doi: 10.1164/arrd.1976.113.3.393. [DOI] [PubMed] [Google Scholar]
  12. Kamesh Lavanya, Harper Lorraine, Savage Caroline O. S. ANCA-positive vasculitis. J Am Soc Nephrol. 2002 Jul;13(7):1953–1960. doi: 10.1097/01.asn.0000016442.33680.3e. [DOI] [PubMed] [Google Scholar]
  13. Klockars M., Koskela R. S., Järvinen E., Kolari P. J., Rossi A. Silica exposure and rheumatoid arthritis: a follow up study of granite workers 1940-81. Br Med J (Clin Res Ed) 1987 Apr 18;294(6578):997–1000. doi: 10.1136/bmj.294.6578.997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Koeger A. C., Lang T., Alcaix D., Milleron B., Rozenberg S., Chaibi P., Arnaud J., Mayaud C., Camus J. P., Bourgeois P. Silica-associated connective tissue disease. A study of 24 cases. Medicine (Baltimore) 1995 Sep;74(5):221–237. doi: 10.1097/00005792-199509000-00001. [DOI] [PubMed] [Google Scholar]
  15. Langford Carol A. 15. Vasculitis. J Allergy Clin Immunol. 2003 Feb;111(2 Suppl):S602–S612. doi: 10.1067/mai.2003.80. [DOI] [PubMed] [Google Scholar]
  16. Lippmann M., Eckert H. L., Hahon N., Morgan W. K. Circulating antinuclear and rheumatoid factors in coal miners. A prevalence study in Pennsylvania and West Virginia. Ann Intern Med. 1973 Dec;79(6):807–811. doi: 10.7326/0003-4819-79-6-807. [DOI] [PubMed] [Google Scholar]
  17. MIALL W. E., CAPLAN A., COCHRANE A. L., KILPATRICK G. S., OLDHAM P. D. An epidemiological study of rheumatoid arthritis associated with characteristic chest x-ray appearances in coal-workers. Br Med J. 1953 Dec 5;2(4848):1231–1236. doi: 10.1136/bmj.2.4848.1231. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Mansi Ishak A., Opran Adriana, Rosner Fred. ANCA-associated small-vessel vasculitis. Am Fam Physician. 2002 Apr 15;65(8):1615–1620. [PubMed] [Google Scholar]
  19. Martin J. R., Griffin M., Moore E., Lochead J. A., Edwards A. C., Williams J., Khraishi M. M. Systemic sclerosis (scleroderma) in two iron ore mines. Occup Med (Lond) 1999 Apr;49(3):161–169. doi: 10.1093/occmed/49.3.161. [DOI] [PubMed] [Google Scholar]
  20. Mayes M. D. Epidemiologic studies of environmental agents and systemic autoimmune diseases. Environ Health Perspect. 1999 Oct;107 (Suppl 5):743–748. doi: 10.1289/ehp.99107s5743. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Nowack R., Flores-Suárez L. F., van der Woude F. J. New developments in pathogenesis of systemic vasculitis. Curr Opin Rheumatol. 1998 Jan;10(1):3–11. doi: 10.1097/00002281-199801000-00002. [DOI] [PubMed] [Google Scholar]
  22. Otsuki T., Sakaguchi H., Tomokuni A., Aikoh T., Matsuki T., Kawakami Y., Kusaka M., Ueki H., Kita S., Ueki A. Soluble Fas mRNA is dominantly expressed in cases with silicosis. Immunology. 1998 Jun;94(2):258–262. doi: 10.1046/j.1365-2567.1998.00509.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Parks C. G., Conrad K., Cooper G. S. Occupational exposure to crystalline silica and autoimmune disease. Environ Health Perspect. 1999 Oct;107 (Suppl 5):793–802. doi: 10.1289/ehp.99107s5793. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Parks Christine G., Cooper Glinda S., Nylander-French Leena A., Sanderson Wayne T., Dement John M., Cohen Philip L., Dooley Mary Anne, Treadwell Edward L., St Clair E. William, Gilkeson Gary S. Occupational exposure to crystalline silica and risk of systemic lupus erythematosus: a population-based, case-control study in the southeastern United States. Arthritis Rheum. 2002 Jul;46(7):1840–1850. doi: 10.1002/art.10368. [DOI] [PubMed] [Google Scholar]
  25. Powell J. J., Van de Water J., Gershwin M. E. Evidence for the role of environmental agents in the initiation or progression of autoimmune conditions. Environ Health Perspect. 1999 Oct;107 (Suppl 5):667–672. doi: 10.1289/ehp.99107s5667. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Shida H., Chiyotani K., Honma K., Hosoda Y., Nobechi T., Morikubo H., Wiot J. F. Radiologic and pathologic characteristics of mixed dust pneumoconiosis. Radiographics. 1996 May;16(3):483–498. doi: 10.1148/radiographics.16.3.8897618. [DOI] [PubMed] [Google Scholar]
  27. Sluis-Cremer G. K., Hessel P. A., Hnizdo E., Churchill A. R. Relationship between silicosis and rheumatoid arthritis. Thorax. 1986 Aug;41(8):596–601. doi: 10.1136/thx.41.8.596. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Sluis-Cremer G. K., Hessel P. A., Nizdo E. H., Churchill A. R., Zeiss E. A. Silica, silicosis, and progressive systemic sclerosis. Br J Ind Med. 1985 Dec;42(12):838–843. doi: 10.1136/oem.42.12.838. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Smith D. A., Germolec D. R. Introduction to immunology and autoimmunity. Environ Health Perspect. 1999 Oct;107 (Suppl 5):661–665. doi: 10.1289/ehp.99107s5661. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Steenland K., Goldsmith D. F. Silica exposure and autoimmune diseases. Am J Ind Med. 1995 Nov;28(5):603–608. doi: 10.1002/ajim.4700280505. [DOI] [PubMed] [Google Scholar]
  31. Steenland K., Sanderson W., Calvert G. M. Kidney disease and arthritis in a cohort study of workers exposed to silica. Epidemiology. 2001 Jul;12(4):405–412. doi: 10.1097/00001648-200107000-00010. [DOI] [PubMed] [Google Scholar]
  32. Tervaert J. W., Stegeman C. A., Kallenberg C. G. Silicon exposure and vasculitis. Curr Opin Rheumatol. 1998 Jan;10(1):12–17. doi: 10.1097/00002281-199801000-00003. [DOI] [PubMed] [Google Scholar]
  33. Theofilopoulos A. N., Kono D. H. Mechanisms and genetics of autoimmunity. Ann N Y Acad Sci. 1998 May 13;841:225–235. doi: 10.1111/j.1749-6632.1998.tb10932.x. [DOI] [PubMed] [Google Scholar]
  34. Tomokuni A., Aikoh T., Matsuki T., Isozaki Y., Otsuki T., Kita S., Ueki H., Kusaka M., Kishimoto T., Ueki A. Elevated soluble Fas/APO-1 (CD95) levels in silicosis patients without clinical symptoms of autoimmune diseases or malignant tumours. Clin Exp Immunol. 1997 Nov;110(2):303–309. doi: 10.1111/j.1365-2249.1997.tb08332.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Tomokuni A., Otsuki T., Isozaki Y., Kita S., Ueki H., Kusaka M., Kishimoto T., Ueki A. Serum levels of soluble Fas ligand in patients with silicosis. Clin Exp Immunol. 1999 Dec;118(3):441–444. doi: 10.1046/j.1365-2249.1999.01083.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Watts R. A., Scott D. G. Classification and epidemiology of the vasculitides. Baillieres Clin Rheumatol. 1997 May;11(2):191–217. doi: 10.1016/s0950-3579(97)80043-x. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES